Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
04:33pm, Thursday, 21'st Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days endin
Verve (VERV) Up on Gene Editing Collaboration With Vertex
03:34pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Verve Therapeutics (VERV) enters into a four-year collaboration with Vertex Therapeutics to develop a gene-editing program targeted at liver disease for an upfront payment of $60 million.
Verve (VERV) Up on Gene Editing Collaboration With Vertex
01:14pm, Thursday, 21'st Jul 2022
Verve Therapeutics (VERV) enters into a four-year collaboration with Vertex Therapeutics to develop a gene-editing program targeted at liver disease for an upfront payment of $60 million.
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
10:30am, Thursday, 21'st Jul 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc. (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-cour
Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session
09:53am, Thursday, 21'st Jul 2022 Benzinga
Gainers
Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for custo
Verve Therapeutics, Vertex Join Forces For Liver Disease-Focused Gene Program
07:59am, Thursday, 21'st Jul 2022
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Verve Therapeutics Inc (NASDAQ: VERV) announced an exclusive, four-year global research collaboration to discover and develop an in vivo g
Verve Therapeutics Announces Proposed Public Offering of Common Stock
08:02pm, Wednesday, 20'th Jul 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc. (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-cour
Vertex and Verve Therapeutics Establish Collaboration to Discover and Develop an In Vivo Gene Editing Program for Liver Disease
08:01pm, Wednesday, 20'th Jul 2022 GlobeNewswire Inc.
Verve to Receive $25 Million Upfront Payment and $35 Million Equity Investment, as Well as Potential Milestones and Royalties Verve to Receive $25 Million Upfront Payment and $35 Million Equity Invest
Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch
02:28pm, Wednesday, 20'th Jul 2022 Benzinga
One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a l
AMC, GameStop stocks jump to multi-month intraday highs, then pull back
11:53am, Wednesday, 20'th Jul 2022 MarketWatch
Shares of both AMC Entertainment Holdings Inc. and GameStop Corp. rallied above apparent resistance levels, and reached multi-month highs in intraday trading, before pulling back.
Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
07:59am, Wednesday, 20'th Jul 2022 Benzinga
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings an
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
08:35am, Tuesday, 19'th Jul 2022 Benzinga
Gainers
AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.
SKYX Platforms Corp. (NASDAQ: SKYX) jumped
Why Did BMO Capital Markets Raise Price Target For Gene Stock One Month After Initiating Coverage
04:45pm, Monday, 18'th Jul 2022 Benzinga
BMO Capital Markets has raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $61 from $41, with a Market Perform rating unchanged.
The model changes include updated collaboration re
Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
04:05pm, Monday, 18'th Jul 2022 Benzinga
Gainers
Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.
Verve Therapeutics Doses First Human with an Investigational In Vivo Base Editing Medicine, VERVE-101, as a Potential Treatment for Heterozygous Familial Hypercholesterolemia
10:30am, Tuesday, 12'th Jul 2022 GlobeNewswire Inc.
Phase 1b Clinical Trial, heart-1, Now Underway and Enrolling Patients with Heterozygous Familial Hypercholesterolemia in New Zealand
